Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Next-Generation Sequencing on Surgical Decision-Making in Branch-Duct IPMN.

Annals of surgical oncology - 1 Sept 2026

Remy Maxime, Albouys Jeremie, Birnbaum David Jérémie, Gaujoux Sebastien, Védie Anne Laure, Descourvières Clémence, Gonzalez Jean Michel, Lorenzo Diane

Abstract excerpt

BACKGROUND: Managing branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) remains challenging, as guideline criteria (worrisome features/high-risk stigmata) and nomograms often leave uncertainty. Next-generation sequencing (NGS) may provide actionable molecular information that influences clinical decision-making. METHODS: We conducted a national, vignette-based decision-impact study involving 132...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Mucinous
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Clinical Decision-Making

Share to Follow-Up Studies

Share to High-Throughput Nucleotide Sequencing

Share to Pancreatectomy

Share to Pancreatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 42342971
DOI: 10.1245/s10434-026-20023-6
PMCID: PMC13452778

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Impact of Next-Generation Sequencing on Surgical Decision-Making in Branch-Duct IPMN.PMID 42342971Read ↗

Use of an Algo‐Based Decision‐Making Tool to Compare Real‐Life Clinical Practice in a Single Tertiary Center with the Kyoto IPMN Surveillance RecommendationsSemantic proximity Read ↗

Clinical utility of incorporating next-generation sequencing results in the management algorithm of pancreatic cysts.Semantic proximity Read ↗

Molecular Analysis of Mixed-Type and Branch-Duct Intraductal Papillary Mucinous Neoplasms.Semantic proximity Read ↗

Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort.Semantic proximity Read ↗

Next-generation sequencing improves diagnostic accuracy of imaging and carcinoembryonic antigen alone for pancreatic cystic neoplasms.Semantic proximity Read ↗

Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.Semantic proximity Read ↗

Cytology and KRAS/GNAS Molecular Testing of Pancreatic Cyst Fluid for Risk Stratification of Intraductal Papillary Mucinous Neoplasms: a Single-Center Study with Histological CorrelationSemantic proximity Read ↗

Percepta Genomic Sequencing Classifier And Decision-Making In Patients With High-Risk Lung Nodules: A Decision Impact StudySemantic proximity Read ↗

Changes to management influenced by next-generation sequencing of pancreatic duct aspirates among patients with main pancreatic duct dilatation of unclear etiology: a multicenter cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.